Publications

1. Dehner CA, Johnson EF, Wieland CN, Camilleri MJ, Kajdacsy-Balla A, Oliveira AM, Halling KC, Gupta S, Guo R. Fusion-driven cutaneous and superficial mesenchymal and adnexal tumors-A clinicopathologic and molecular study of 15 cases, including a novel case of ACTB::ZMIZ2-rearranged adnexal carcinoma. J Cutan Pathol. 2024 Jul; 51 (7):538-548 Epub 2024 Mar 31
   View PubMed
2. Tekin B, Sali AP, Menon S, Cheville JC, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Cubilla AL, Whaley RD, Hernandez LH, Jimenez RE, Garcia JJ, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Comparison of a modified staging system with 8th edition AJCC criteria in a North American cohort of pT2/pT3 HPV-negative penile squamous cell carcinoma. Hum Pathol. 2024 Jun; 148:81-86 Epub 2024 May 22
   View PubMed
3. Lobo J, Tavares NT, Jeronimo C, Henrique R, Dvindenko E, Cornejo KM, Berney DM, Ulbright TM, Gupta S, Acosta AM. Analysis of MicroRNA-371-373 supports that a subset of spermatocytic tumors demonstrates biologic features similar to those of GCNIS-derived germ cell tumors. Hum Pathol. 2024 Jun; 148:66-71 Epub 2024 May 21
   View PubMed
4. Schembri-Wismayer D, Gupta S, Erickson LA. Cutaneous Adenoid Cystic Carcinoma. Mayo Clin Proc. 2024 Jun; 99 (6):1017-1018
   View PubMed
5. Zganjar A, Khanna A, Joyce D, Nichols P, Britton C, Lohse CM, Cheville JC, Gupta S, Potretzke AM, Thompson RH, Leibovich BC, Boorjian SA, Sharma V. Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma. J Urol. 2024 May 30; 101097JU0000000000004030 [Epub ahead of print]
   View PubMed
6. Zganjar A, Khanna A, Joyce D, Nichols P, Britton C, Lohse CM, Cheville JC, Gupta S, Potretzke AM, Thompson RH, Leibovich BC, Boorjian SA, Sharma V. Reply by Authors. J Urol. 2024 May 30; 101097JU0000000000004068 [Epub ahead of print]
   View PubMed
7. Pagliaro LC, Tekin B, Gupta S, Herrera Hernandez L. Therapeutic Targets in Advanced Penile Cancer: From Bench to Bedside Cancers. 2024; 16(11):2086.
   
8. Whaley RD, Tekin B, McCarthy MR, Zia HM, Pitel BA, Al-Kateb H, Cheville JC, Gupta S. NTRK3-Rearranged Prostatic Acinar Adenocarcinoma: Report of a Patient and Review of the Literature. Int J Surg Pathol. 2024 May 21; 10668969241253197 [Epub ahead of print]
   View PubMed
9. Tekin B, Gupta S, Erickson LA. Sebaceous Neoplasm With Defective DNA Mismatch Repair. Mayo Clin Proc. 2024 May; 99 (5):846-848
   View PubMed
10. Gupta S, Cheville JC. Mesothelioma of Uncertain Malignant Potential (MUMP) of the Tunica Vaginalis: Proposal for Reclassification as "Complex Mesothelial Tumor of the Tunica Vaginalis". Am J Surg Pathol. 2024 Apr 8 Epub 2024 Apr 08
    View PubMed
11. Gupta S, Dasari S, Sharma V, Atwell TD, Sivasankaran G, Smoley SA, Hardcastle JJ, Lohse CM, Tekin B, Jimenez RE, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC. Metastatic clear cell papillary renal cell 'tumour'. Histopathology 2024 Apr; 84 (5):905-909 Epub 2023 Dec 26
    View PubMed
12. Tekin B, Erickson LA, Gupta S. Secondary Involvement of the Urinary Bladder by Endometrial Carcinoma. Mayo Clin Proc. 2024 Apr; 99 (4):680-682
    View PubMed
13. Nielson KJ, Rowsey R, Dasari S, Sukov WR, Kipp BR, Raghunathan A, Whaley RD, Ebare K, Stanton ML, Reynolds JP, Sharma V, Thompson RH, Boorjian SA, Leibovich BC, Hernandez LH, Jimenez RE, Cheville JC, Gupta S. Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation study. Hum Pathol. 2024 Apr; 146:57-65 Epub 2024 Apr 12
    View PubMed
14. Whaley RD, Gupta S, Erickson LA. Oncocytic Poorly Differentiated Thyroid Carcinoma. Mayo Clin Proc. 2024 Mar; 99 (3):511-512
    View PubMed
15. Dasari S, McCarthy MR, Wojcik AA, Pitel BA, Samaddar A, Tekin B, Whaley RD, Raghunathan A, Hernandez LH, Jimenez RE, Stish BJ, Thompson RH, Leibovich BC, Boorjian SA, Jeffrey Karnes R, Childs DS, Quevedo JF, Kwon ED, Pagliaro LC, Costello BA, Halling KC, Cheville JC, Kipp BR, Gupta S. Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients. Prostate Cancer Prostatic Dis. 2024 Feb 27. [Epub ahead of print]
    View PubMed
16. Wang XM, Mannan R, Zhang Y, Chinnaiyan A, Rangaswamy R, Chugh S, Su F, Cao X, Wang R, Skala SL, Hafez KS, Vaishampayan U, Mckenney J, Picken MM, Gupta S, Alaghehbandan R, Tretiakova M, Argani P, Chinnaiyan AM, Dhanasekaran SM, Mehra R. Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dube Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT. Am J Surg Pathol. 2024 Feb 1; 48 (2):163-173 Epub 2023 Nov 24
    View PubMed
17. Dehner CA, Torres-Mora J, Gupta S, Kipp BR, Halling KC, Chen S, Warmke LM, Michal M, Alani A, Yu W, Kovacs K, Obeidin F, Iwenofu OH, Satturwar S, Meis JM, Folpe AL. Sarcomas Harboring EWSR1::PATZ1 Fusions: A Clinicopathologic Study of 17 Cases. Mod Pathol. 2024 Feb; 37 (2):100400 Epub 2023 Dec 01
    View PubMed
18. Patil A, Erickson LA, Gupta S. Sporadic Prostate Cancer in a Patient With Lynch Syndrome. Mayo Clin Proc. 2024 Feb; 99 (2):344-345
    View PubMed
19. Tekin B, Erickson LA, Gupta S. von Hippel-Lindau disease-related neoplasia with an emphasis on renal manifestations. Semin Diagn Pathol. 2024 Jan; 41 (1):20-27 Epub 2023 Nov 08
    View PubMed
20. Gupta S, Whaley RD, Erickson LA. Pancreatic Neuroendocrine Tumor in a Patient With Multiple Endocrine Neoplasia Type 4. Mayo Clin Proc. 2024 Jan; 99 (1):177-178
    View PubMed
21. Swanson AA, Michal M, Xing D, Dashti NK, Zidlik V, Cheek-Norgan EH, Keeney ME, Keeney GL, Sukov WR, Gupta S, Nucci MR, Schoolmeester JK. Malignant female genital tract smooth muscle tumors with adipocytic differentiation: A morphologic, immunohistochemical, MDM2 fluorescence in situ hybridization and molecular genetic study of 6 lipoleiomyosarcomas. Hum Pathol. 2024 Jan; 143:24-32 Epub 2023 Nov 23
    View PubMed
22. Gupta S, Sholl LM, Yang Y, Osunkoya AO, Gordetsky JB, Cornejo KM, Michalova K, Maclean F, Dvindenko E, Snuderl M, Hirsch MS, Anderson WJ, Rowsey RA, Jimenez RE, Cheville JC, Sadow PM, Colecchia M, Ricci C, Ulbright TM, Berney DM, Acosta AM. Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior. J Pathol. 2024 Jan; 262 (1):50-60 Epub 2023 Oct 04
    View PubMed
23. Gagnon MF, Schoolmeester JK, Dasari S, Kipp BR, Cheville JC, Gupta S. Molecular alterations in primary and metastatic PEComa: insights from the AACR project GENIE data set. Hum Pathol 2024 Jan; 143:75-76 Epub 2023 Oct 06
    View PubMed
24. Gupta S, Erickson LA. Metastatic Lung Adenocarcinoma Presenting as Hydrocele. Mayo Clin Proc. 2023 Dec; 98 (12):1894-1896
    View PubMed
25. Swanson AA, Michal M, Xing D, Zidlik V, Cheek-Norgan EH, Keeney ME, Keeney GL, Sukov WR, Gupta S, Nucci MR, Schoolmeester JK. Benign female genital tract smooth muscle tumors with adipocytic differentiation: A morphologic, immunohistochemical and MDM2 fluorescence in situ hybridization study of 44 conventional lipoleiomyomas and lipoleiomyoma variants. Hum Pathol. 2023 Dec; 142:51-61 Epub 2023 Nov 14
    View PubMed
26. Tekin B, Cheville JC, Herrera Hernandez L, Negron V, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Menon S, Cubilla AL, Whaley RD, Jimenez RE, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma. Hum Pathol. 2023 Dec; 142:42-50. Epub 2023 Nov 15.
    View PubMed
27. Gilani SI, Dasari S, Tekin B, Hernandez LH, Cheville JC, Jimenez RE, Rech KL, Dao LN, Howard MT, Dalland JC, Chiu A, Theis JD, Vrana JA, Grogan M, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Dispenzieri A, McPhail ED, Gupta S. Identification of amyloidosis of the urinary tract and prostate: Opportunities for early diagnosis & intervention in systemic disease. Hum Pathol. 2023 Dec; 142:62-67. Epub 2023 Nov 17.
    View PubMed
28. Koshyk O, Dehner CA, van den Hout MFCM, Bempt IV, Sciot R, Huang HY, Agaimy A, Din NU, Klubickova N, Mosaieby E, Skalova A, Michalova K, Schoffski P, Oliveira AM, Halling KC, Gupta S, Gross JM, Nin JWM, Michal M, Folpe AL, Kosemehmetoglu K, Torres-Mora J, Michal M. EWSR1::POU2AF3(COLCA2) Sarcoma: An Aggressive, Polyphenotypic Sarcoma With a Head and Neck Predilection. Mod Pathol. 2023 Dec; 36 (12):100337 Epub 2023 Sept 22
    View PubMed
29. Tekin B, Enninga EAL, Norgan AP, Erickson LA, Vanderbilt C, Gupta S, Guo R. Panviral metagenomic sequencing provides further evidence for human papillomavirus 42 association with digital papillary adenocarcinoma. Hum Pathol 2023 Nov 14 [Epub ahead of print]
    View PubMed
30. Gupta S, Swanson AA, Erickson LA. PAX8-Positive (Gynecologic-Type) Clear Cell Carcinoma Metastatic to the Kidney. Mayo Clin Proc. 2023 Oct; 98 (10):1583-1585
    View PubMed
31. Dehner CA, Broski SM, Meis JM, Murugan P, Chrisinger JSA, Sosa C, Petersen M, Halling KC, Gupta S, Folpe AL. Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases. Mod Pathol. 2023 Oct; 36 (10):100271 Epub 2023 July 07
    View PubMed
32. Falahkheirkhah K, Mukherjee SS, Gupta S, Herrera-Hernandez L, McCarthy MR, Jimenez RE, Cheville JC, Bhargava R. Accelerating Cancer Histopathology Workflows with Chemical Imaging and Machine Learning. Cancer Res Commun. 2023 Sep 18; 3(9):1875-1887.
    View PubMed
33. Mannan R, Wang X, Bawa PS, Zhang Y, Skala SL, Chinnaiyan AK, Dagar A, Wang L, Zelenka-Wang SB, McMurry LM, Daniel N, Cao X, Sangoi AR, Gupta S, Vaishampayan UN, Hafez KS, Morgan TM, Spratt DE, Tretiakova MS, Argani P, Chinnaiyan AM, Dhanasekaran SM, Mehra R. Characterization of Intercalated Cell Markers KIT and LINC01187 in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms. Int J Surg Pathol. 2023 Sep; 31 (6):1027-1040 Epub 2022 Oct 16
    View PubMed
34. Tekin B, Gilani SI, Dasari S, Theis JD, Rech KL, Dao LN, Cubilla AL, Herrera Hernandez LP, Jimenez RE, Cheville JC, Dispenzieri A, Howard MT, McPhail ED, Erickson LA, Guo R, Gupta S. Proteomic and Clinicopathologic Assessment of Penile Amyloidosis: A Single Institutional Review of 12 Cases. Am J Clin Pathol. 2023 Sep 1; 160 (3):303-313
    View PubMed
35. Whaley RD, Gupta S, Erickson LA. Mucoepidermoid Carcinoma. Mayo Clin Proc. 2023 Sep; 98 (9):1427-1428
    View PubMed
36. Gross JM, Perret R, Coindre JM, Le Loarer F, Michal M, Michal M, Miettinen M, McCabe CE, Nair AA, Swanson AA, Thangaiah JJ, Torres-Mora J, Bonadio A, Voltaggio L, Epstein JI, Gupta S, Folpe AL, Schoolmeester JK. Lipoblastoma-Like Tumor and Fibrosarcoma-Like Lipomatous Neoplasm Represent the Same Entity: A Clinicopathologic and Molecular Genetic Study of 23 Cases Occurring in Both Men and Women at Diverse Locations. Mod Pathol. 2023 Sep; 36 (9):100246 Epub 2023 June 10
    View PubMed
37. Blum KA, Silagy AW, Knezevic A, Weng S, Wang A, Mano R, Marcon J, DiNatale RG, Sanchez A, Tickoo S, Gupta S, Motzer R, Haas NB, Kim SE, Uzzo RG, Coleman JA, Hakimi AA, Russo P. Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study. BJU Int. 2023 Aug 17 [Epub ahead of print]
    View PubMed
38. Gupta S, Schoolmeester JK, Erickson LA. Gynecologic-Type Adenocarcinoma With Mixed Serous and Endometrioid Features in a Male Patient. Mayo Clin Proc. 2023 Aug; 98 (8):1260-1262
    View PubMed
39. McCarthy MR, Nichols PE, Sharma V, Stanton ML, Reynolds JP, Pitel BA, Halling KC, Lohse CM, Herrera-Hernandez L, Thompson RH, Leibovich BC, Jimenez RE, Boorjian SA, Cheville JC, Gupta S. Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1, and ATRX. Arch Pathol Lab Med. 2023 Jul 01; 147(7):817-825.
    View PubMed
40. Gupta S, Norgan AP, Erickson LA. Schistosomiasis of the Urinary Bladder. Mayo Clin Proc. 2023 Jul; 98 (7):1100-1101
    View PubMed
41. Tang C, Xie AX, Liu EM, Kuo F, Kim M, DiNatale RG, Golkaram M, Chen YB, Gupta S, Motzer RJ, Russo P, Coleman J, Carlo MI, Voss MH, Kotecha RR, Lee CH, Tansey W, Schultz N, Hakimi AA, Reznik E. Immunometabolic coevolution defines unique microenvironmental niches in ccRCC. Cell Metab. 2023 Jun 28 Epub 2023 June 28
    View PubMed
42. Gupta S, Erickson LA. Papillary Endothelial Hyperplasia. Mayo Clin Proc. 2023 Jun; 98 (6):950-951
    View PubMed
43. Hopkins M, Gupta S, Erickson LA. Perianal Treponema pallidum. Mayo Clin Proc. 2023 May; 98 (5):807-809
    View PubMed
44. Tekin B, Dasari S, Theis JD, Vrana JA, Murray DL, Oglesbee D, Thompson RH, Leibovich BC, Boorjian SA, Whaley RD, Hernandez LH, Jimenez RE, Cheville JC, Karnes RJ, Sukov WR, Gupta S. Mass spectrometry-based assessment of prostate cancer-associated crystalloids reveals enrichment for growth and differentiation factor 15. Hum Pathol. 2023 May; 135:35-44 Epub 2023 Mar 09
    View PubMed
45. Tekin B, Guo R, Cheville JC, Canete-Portillo S, Sanchez DF, Fernandez-Nestosa MJ, Dasari S, Menon S, Herrera-Hernandez L, Jimenez RE, Erickson LA, Cubilla AL, Gupta S. Penile squamous cell carcinoma exclusive to the shaft, with a proposal for a novel staging system. Hum Pathol. 2023 Apr; 134:92-101 Epub 2022 Dec 23
    View PubMed
46. McCarthy MR, Gupta S, Erickson LA. Acquired Cystic Disease-Associated Renal Cell Carcinoma. Mayo Clin Proc. 2023 Apr; 98 (4):637-638
    View PubMed
47. Mannan R, Wang X, Bawa PS, Chugh S, Chinnaiyan AK, Rangaswamy R, Zhang Y, Cao X, Smith SC, Trpkov K, Williamson SR, Sangoi AR, Mohanty S, McKenney JK, Gupta S, Magi-Galluzzi C, Argani P, Osunkoya AO, Chinnaiyan AM, Dhanasekaran SM, Mehra R. Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma. Hum Pathol. 2023 Apr; 134:102-113 Epub 2022 Dec 26
    View PubMed
48. Erickson LA, Rivera M, Guo R, Torres-Mora J, Gupta S. Thyroblastoma-a Primitive Multilineage Thyroid Neoplasm with Somatic DICER1 Alteration. Endocr Pathol. 2023 Mar; 34 (1):159-160 Epub 2023 Feb 15
    View PubMed
49. Gupta S, Erickson LA. Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas. Surg Pathol Clin. 2023 Mar; 16 (1):119-129
    View PubMed
50. Erickson LA, Gupta S, Torres-Mora J. Hepatic Hemangioma. Mayo Clin Proc. 2023 Mar; 98 (3):489-491
    View PubMed
51. Gupta S, Stanton ML, Reynolds JP, Whaley RD, Herrera-Hernandez L, Jimenez RE, Cheville JC. Reprint of: lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas & renal cell carcinoma. Hum Pathol. 2023 Mar; 133:136-152 Epub 2023 Mar 07
    View PubMed
52. Erickson LA, Whaley RD, Gupta S. Adrenal Epithelial Cysts. Mayo Clin Proc. 2023 Feb; 98 (2):353-354
    View PubMed
53. Falahkheirkhah K, Tiwari S, Yeh K, Gupta S, Herrera-Hernandez L, McCarthy MR, Jimenez RE, Cheville JC, Bhargava R. Deepfake Histologic Images for Enhancing Digital Pathology. Lab Invest. 2023 Jan; 103(1):100006.
    View PubMed
54. Raghunathan A, Ida CM, Westbroek EM, Gupta S, Jenkins RB, Giannini C, Aldape KD. Mutations of FH and IDH may induce gliomagenesis by similar mechanisms. J Neuropathol Exp Neurol 2022 Dec 19; 82 (1):99-100
    View PubMed
55. Gupta S, Sukov WR, Vanderbilt CM, Shen W, Herrera-Hernandez L, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE, Cheville JC. A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma. Urol Oncol. 2022 Dec; 40 (12):512-524 Epub 2021 June 04
    View PubMed
56. Gupta S, Erickson LA. The Cytogenetic Profile of Spindle Cell-Predominant Mucinous Tubular and Spindle Cell Carcinoma. Mayo Clin Proc. 2022 Dec; 97 (12):2387-2388
    View PubMed
57. Gupta S, Nichols P, Lohse CM, Kosari F, Kattah AG, Harris FR, Karagouga G, Mehra R, Fine SW, Reuter VE, Herrera-Hernandez L, Zganjar AJ, Britton CJ, Potretzke AM, Boorjian SA, Thompson RH, Jimenez RE, Leibovich BC, Garovic VD, Cheville JC, Sharma V. Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors. Mayo Clin Proc. 2022 Nov; 97 (11):2050-2064 Epub 2022 June 24
    View PubMed
58. Gupta S, Stanton ML, Reynolds JP, Whaley RD, Herrera-Hernandez L, Jimenez RE, Cheville JC. Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma. Hum Pathol. 2022 Nov; 129:123-139 Epub 2022 Sept 14
    View PubMed
59. Kerper AL, Clarke-Brodber AL, Gupta S, Whalen KM, Nigdelioglu R, Boland JM, Schembri Wismayer DJ, Torres-Mora J, Mejia Acevedo MR, Sudhindran V, Sturgis CD. Malignant rhabdoid tumor: Cyto-histologic correlation and immunohistochemical characterization of a rare pediatric malignancy and its differential diagnoses. Ann Diagn Pathol. 2022 Oct; 60:152014 Epub 2022 July 22
    View PubMed
60. Gupta S, Folpe AL, Torres-Mora J, Reuter VE, Zuckerman JE, Falk N, Stanton ML, Muthusamy S, Smith SC, Sharma V, Sethi S, Herrera-Hernandez L, Jimenez RE, Cheville JC. Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumors. Hum Pathol. 2022 Oct; 128:110-123 Epub 2022 Aug 01
    View PubMed
61. Zafar R, Schrader LJ, Cheville JC, Schoolmeester JK, Roden AC, Aubry MC, Yi ES, Raghunathan A, Herrera-Hernandez L, Thompson RH, Boorjian SA, Leibovich BC, Keeney GL, Jimenez RE, Gupta S. A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma. Hum Pathol. 2022 Oct; 128:31-47. Epub 2022 Jul 06.
    View PubMed
62. Gupta S, Erickson LA. Prepubertal-Type Testicular Tumors in Postpubertal Patients: Epidermoid Cyst and Well-Differentiated Neuroendocrine Tumor. Mayo Clin Proc. 2022 Oct; 97 (10):1956-1957
    View PubMed
63. Hu C, Susswein LR, Roberts ME, Yang H, Marshall ML, Hiraki S, Berkofsky-Fessler W, Gupta S, Shen W, Dunn CA, Huang H, Na J, Domchek SM, Yadav S, Monteiro ANA, Polley EC, Hart SN, Hruska KS, Couch FJ. Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay. Clin Cancer Res. 2022 Sep 01; 28(17):3742-3751.
    View PubMed
64. Gupta S, Guo R, Erickson LA. Anaplastic Thyroid Carcinoma, Squamous Cell Carcinoma Pattern. Mayo Clin Proc. 2022 Aug; 97 (8):1584-1585
    View PubMed
65. Gupta S, Erickson LA. Postirradiation Angiosarcoma of the Urinary Bladder. Mayo Clin Proc. 2022 Jul; 97 (7):1406-1408
    View PubMed
66. Mahmoud AM, Frank I, Orme JJ, Lavoie RR, Thapa P, Costello BA, Cheville JC, Gupta S, Dong H, Lucien F. Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer. BMC Urol. 2022 Jun 24; 22 (1):90 Epub 2022 June 24
    View PubMed
67. Carlo MI, Attalla K, Mazaheri Y, Gupta S, Yildirim O, Murray SJ, Coskey DT, Kotecha R, Lee CH, Feldman DR, Russo P, Patil S, Motzer RJ, Coleman JA, Durack JC, Chen YB, Akin O, Ari Hakimi A, Voss MH. Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy. Eur Urol. 2022 Jun; 81 (6):570-573 Epub 2022 Feb 17
    View PubMed
68. Gupta S, Farooq A, Rowsey RA, Rahman MA, Shen W, Herrera-Hernandez L, Raghunathan A, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC, Jimenez RE. Cytogenetics of spermatocytic tumors with a discussion of gain of chromosome 12p in anaplastic variants. Hum Pathol. 2022 Jun; 124:85-95 Epub 2022 Apr 01
    View PubMed
69. McCarthy MR, Tiegs-Heiden CA, Sturgis CD, Swanson AA, Gupta S, Thangaiah JJ, Hartley CP. Biphasic squamoid alveolar renal cell carcinoma: Cytologic features of a rare entity. Ann Diagn Pathol. 2022 Jun; 58:151906 Epub 2022 Feb 03
    View PubMed
70. Gupta S, Won H, Chadalavada K, Nanjangud GJ, Chen YB, Al-Ahmadie HA, Fine SW, Sirintrapun SJ, Strong VE, Raj N, Lagunes DR, Vanderbilt CM, Berger MF, Ladanyi M, Dogan S, Tickoo SK, Reuter VE, Gopalan A. TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas. Endocr Pathol. 2022 Jun; 33 (2):304-314 Epub 2021 Sept 22
    View PubMed
71. Gupta S, Herrera-Hernandez L, Erickson LA. Amyloid Involving the Seminal Vesicles. Mayo Clin Proc. 2022 Jun; 97 (6):1213-1214
    View PubMed
72. Chatzopoulos K, Aubry MC, Gupta S. Immunohistochemical expression of carbonic anhydrase 9, glucose transporter 1, and paired box 8 in von Hippel-Lindau disease-related lesions. Hum Pathol. 2022 May; 123:93-101 Epub 2022 Feb 20
    View PubMed
73. Gupta S, Menon S, Raghunathan A, Herrera-Hernandez L, Jimenez RE, Cheville JC. Do We Have Sufficient Evidence to Define Prognosis for "Low-grade" Fumarate Hydratase-deficient Renal Cell Carcinoma? Adv Anat Pathol 2022 May 1; 29 (3):178-181
    View PubMed
74. Vanderbilt CM, Bowman AS, Middha S, Petrova-Drus K, Tang YW, Chen X, Wang Y, Chang J, Rekhtman N, Busam KJ, Gupta S, Hameed M, Arcila ME, Ladanyi M, Berger MF, Dogan S, Zehir A. Defining Novel DNA Virus-Tumor Associations and Genomic Correlates Using Prospective Clinical Tumor/Normal Matched Sequencing Data. J Mol Diagn. 2022 May; 24 (5):515-528 Epub 2022 Mar 22
    View PubMed
75. Momeni-Boroujeni A, Yousefi E, Gupta S, Benayed R, Berger MF, Ladanyi M, Monroe R, Kim J, Jungbluth A, Weigelt B, Park KJ. Evaluation of TERT mRNA expression using RNAscope(R): A potential histopathologic diagnostic and prognostic tool. Pathol Res Pract. 2022 May; 233:153892 Epub 2022 Apr 16
    View PubMed
76. Gupta S, Erickson LA. Papillary Renal Cell Carcinoma With "Drop Metastasis" (Tumor Seeding) Involving the Distal Ureter. Mayo Clin Proc. 2022 May; 97 (5):1026-1028
    View PubMed
77. Erickson LA, Gupta S. STAT6 Immunopositivity in Solitary Fibrous Tumor of Thyroid Gland. Mayo Clin Proc. 2022 Apr; 97 (4):808-810
    View PubMed
78. Gupta S, Swanson AA, Erickson LA. Renal Cell Carcinoma With Combined Loss of Fumarate Hydratase and SMARCB1/INI-1. Mayo Clin Proc. 2022 Mar; 97 (3):630-632
    View PubMed
79. Gupta S, Lohse CM, Rowsey R, McCarthy MR, Shen W, Herrera-Hernandez L, Boorjian SA, Houston Thompson R, Jimenez RE, Leibovich BC, Cheville JC. Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex-associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome. Eur Urol. 2022 Mar; 81 (3):229-233 Epub 2021 Dec 06
    View PubMed
80. Taylor AS, Newell B, Chinnaiyan AM, Hafez KS, Weizer AZ, Spratt DE, Cameron AP, Al-Ahmadie HA, Gupta S, Montgomery JS, Betz BL, Brown N, Mehra R. TERT Promoter Mutations in Keratinizing and Nonkeratinizing Squamous Metaplasia of the Urinary Tract. Eur Urol Open Sci. 2022 Jan; 35:74-78 Epub 2022 Jan 03
    View PubMed
81. Gupta S, Lipworth R, Mynderse LA. Papillary Urothelial Carcinoma. Mayo Clin Proc. 2021 Nov; 96 (11):2746-2747
    View PubMed
82. Gupta S, Erickson LA, Lohse CM, Shen W, Pitel BA, Knight SM, Halling KC, Herrera-Hernandez L, Boorjian SA, Thompson RH, Leibovich BC, Jimenez RE, Cheville JC. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia. JAMA Netw Open. 2021 Nov 1; 4 (11):e2132615 Epub 2021 Nov 01
    View PubMed
83. Gupta S, Erickson LA. Renal Neoplasia in Hyperparathyroidism-Jaw Tumor Syndrome. Mayo Clin Proc. 2021 Oct; 96 (10):2730-2731
    View PubMed
84. Rizzo NM, Sholl LM, Idrees MT, Cheville JC, Gupta S, Cornejo KM, Miyamoto H, Hirsch MS, Collins K, Acosta AM. Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features. Mod Pathol. 2021 Oct; 34 (10):1935-1946 Epub 2021 June 08
    View PubMed
85. Wang XM, Zhang Y, Mannan R, Skala SL, Rangaswamy R, Chinnaiyan A, Su F, Cao X, Zelenka-Wang S, McMurry L, Xiao H, Spratt DE, Sangoi AR, Shao L, Betz BL, Brown N, Tickoo SK, McKenney JK, Argani P, Gupta S, Reuter VE, Chinnaiyan AM, Dhanasekaran SM, Mehra R. TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma. Mod Pathol. 2021 Aug; 34 (8):1596-1607 Epub 2021 Apr 14
    View PubMed
86. Kravtsov O, Gupta S, Cheville JC, Sukov WR, Rowsey R, Herrera-Hernandez LP, Lohse CM, Knudson R, Leibovich BC, Jimenez RE. Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics. Hum Pathol. 2021 Aug; 114:9-18 Epub 2021 May 04
    View PubMed
87. Amin MB, Comperat E, Epstein JI, True LD, Hansel D, Paner GP, Al-Ahmadie H, Baydar D, Bivalacqua T, Brimo F, Cheng L, Cheville J, Dalbagni G, Falzarano S, Gordetsky J, Guo CC, Gupta S, Hes O, Iyer G, Kaushal S, Kunju L, Magi-Galluzzi C, Matoso A, Netto G, Osunkoya AO, Pan CC, Pivovarcikova K, Raspollini MR, Reis H, Rosenberg J, Roupret M, Shah RB, Shariat S, Trpkov K, Weyerer V, Zhou M, McKenney J, Reuter VE. The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia. Adv Anat Pathol. 2021 Jul 1; 28 (4):179-195
    View PubMed
88. Comperat E, Amin MB, Epstein JI, Hansel DE, Paner G, Al-Ahmadie H, True L, Bayder D, Bivalacqua T, Brimo F, Cheng L, Cheville J, Dalbagni G, Falzarano S, Gordetsky J, Guo C, Gupta S, Hes O, Iyer G, Kaushal S, Kunju L, Magi-Galluzzi C, Matoso A, McKenney J, Netto GJ, Osunkoya AO, Pan CC, Pivovarcikova K, Raspollini MR, Reis H, Rosenberg J, Roupret M, Shah RB, Shariat SF, Trpkov K, Weyerer V, Zhou M, Reuter V. The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. Adv Anat Pathol. 2021 Jul 1; 28 (4):196-208
    View PubMed
89. Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Gill AJ. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021 Jul; 34 (7):1392-1424 Epub 2021 Mar 04
    View PubMed
90. Gupta S, Erickson LA. Primary Renal Well-Differentiated Neuroendocrine Tumor (Carcinoid) in a Horseshoe Kidney. Mayo Clin Proc. 2021 Jun; 96 (6):1687-1688
    View PubMed
91. Freitag CE, Sukov WR, Bryce AH, Berg JV, Vanderbilt CM, Shen W, Smadbeck JB, Greipp PT, Ketterling RP, Jenkins RB, Herrera-Hernandez L, Costello BA, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE, Murphy SJ, Vasmatzis G, Cheville JC, Gupta S. Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing. Hum Pathol. 2021 Jun; 112:20-34 Epub 2021 Mar 31
    View PubMed
92. Gupta S, Jimenez RE, Herrera-Hernandez L, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC. Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients. Mayo Clin Proc. 2021 Jun; 96 (6):1470-1489 Epub 2021 Jan 29
    View PubMed
93. Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021 Jun; 34 (6):1167-1184 Epub 2021 Feb 01
    View PubMed
94. Krishna C, DiNatale RG, Kuo F, Srivastava RM, Vuong L, Chowell D, Gupta S, Vanderbilt C, Purohit TA, Liu M, Kansler E, Nixon BG, Chen YB, Makarov V, Blum KA, Attalla K, Weng S, Salmans ML, Golkaram M, Liu L, Zhang S, Vijayaraghavan R, Pawlowski T, Reuter V, Carlo MI, Voss MH, Coleman J, Russo P, Motzer RJ, Li MO, Leslie CS, Chan TA, Hakimi AA. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. Cancer Cell. 2021 May 10; 39 (5):662-677.e6 Epub 2021 Apr 15
    View PubMed
95. Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O. Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021 May; 34 (5):1037
    View PubMed
96. Akgul M, Williamson SR, Ertoy D, Argani P, Gupta S, Calio A, Reuter V, Tickoo S, Al-Ahmadie HA, Netto GJ, Hes O, Hirsch MS, Delahunt B, Mehra R, Skala S, Osunkoya AO, Harik L, Rao P, Sangoi AR, Nourieh M, Zynger DL, Smith SC, Nazeer T, Gumuskaya B, Kulac I, Khani F, Tretiakova MS, Vakar-Lopez F, Barkan G, Molinie V, Verkarre V, Rao Q, Kis L, Panizo A, Farzaneh T, Magers MJ, Sanfrancesco J, Perrino C, Gondim D, Araneta R, So JS, Ro JY, Wasco M, Hameed O, Lopez-Beltran A, Samaratunga H, Wobker SE, Melamed J, Cheng L, Idrees MT. Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey. J Clin Pathol. 2021 May; 74 (5):291-299 Epub 2021 Jan 29
    View PubMed
97. Gupta S, Erickson LA. Paratesticular Papillary Cystadenoma of the Epididymis in the Setting of von Hippel-Lindau. Mayo Clin Proc. 2021 Mar; 96 (3):828-829
    View PubMed
98. Avulova S, Cheville JC, Lohse CM, Gupta S, Potretzke TA, Tsivian M, Thompson RH, Boorjian SA, Leibovich BC, Potretzke AM. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol. 2021 Feb; 79 (2):225-231 Epub 2020 Nov 07
    View PubMed
99. Zhao Y, Yu H, Ida CM, Halling KC, Kipp BR, Geiersbach K, Rumilla KM, Gupta S, Lin MT, Zheng G. Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases. JAMA Netw Open. 2021 Jan 04; 4(1):e2035479.
    View PubMed
100. Gupta S, Vanderbilt CM, Zhang Y, Tickoo SK, Fine SW, Gopalan A, Chen YB, Sirintrapun SJ, Teo MY, Funt SA, Iyer G, Rosenberg JE, Bajorin DF, Bochner BH, Pietzak EJ, Ross DS, Ladanyi M, Cheville JC, Solit DB, Reuter VE, Al-Ahmadie HA. CD274 (PD-L1) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract. Bladder Cancer. 2021; 7 (4):395-400 Epub 2021 Dec 13
     View PubMed
101. Gupta S, Cheville JC, Galeano BK, Sukov WR, Herrera-Hernandez L, Reed KA, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE. Renal neoplasia with papillary architecture involving the pelvicalyceal system. Hum Pathol. 2021 Jan; 107:46-57 Epub 2020 Nov 06
     View PubMed
102. Gupta S, Vanderbilt CM, Lin YT, Benhamida JK, Jungbluth AA, Rana S, Momeni-Boroujeni A, Chang JC, Mcfarlane T, Salazar P, Mullaney K, Middha S, Zehir A, Gopalan A, Bale TA, Ganly I, Arcila ME, Benayed R, Berger MF, Ladanyi M, Dogan S. A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing. J Mol Diagn. 2020 Dec 5 Epub 2020 Dec 05
     View PubMed
103. Gupta S, Erickson LA. Renal Neoplasia in Cowden Syndrome. Mayo Clin Proc. 2020 Dec; 95 (12):2808-2809
     View PubMed
104. Aron M, Park S, Lowenthal BM, Gupta S, Sahoo D, Cheville JC, Hansel DE. Primary Female Urethral Carcinoma: Proposed Staging Modifications Based on Assessment of Female Urethral Histology and Analysis of a Large Series of Female Urethral Carcinomas. Am J Surg Pathol. 2020 Dec; 44 (12):1591-1601
     View PubMed
105. Blum KA, Gupta S, Tickoo SK, Chan TA, Russo P, Motzer RJ, Karam JA, Hakimi AA. Sarcomatoid renal cell carcinoma: biology, natural history and management. Nat Rev Urol. 2020 Oct 13 [Epub ahead of print]
     View PubMed
106. Mata DA, Yang SR, Ferguson DC, Liu Y, Sharma R, Benhamida JK, Al-Ahmadie HA, Chakravarty D, Solit DB, Tickoo SK, Gupta S, Arcila ME, Ladanyi M, Feldman DR, Reuter VE, Vanderbilt CM. RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors. Urology. 2020 Oct; 144:111-116 Epub 2020 July 25
     View PubMed
107. Gupta S, Vanderbilt CM, Leibovich BC, Herrera-Hernandez L, Raghunathan A, Sukov WR, Voss JS, Barr Fritcher EG, Reed KA, Lohse CM, Reuter VE, Jimenez RE, Thompson RH, Cheville JC. Secondary renal neoplasia following chemotherapy or radiation in pediatric patients. Hum Pathol. 2020 Sep; 103:1-13 Epub 2020 July 15
     View PubMed
108. Gupta S, Inwards CY, Van Dyke DL, Jimenez RE, Cheville JC. Defining clear cell papillary renal cell carcinoma in routine clinical practice. Histopathology 2020 Jun; 76 (7):1093-1095 Epub 2020 May 07
     View PubMed
109. Gupta S, Erickson LA. Tuberous Sclerosis-Associated Renal Neoplasm. Mayo Clin Proc. 2020 May; 95 (5):1089-1090
     View PubMed
110. Marcon J, DiNatale RG, Sanchez A, Kotecha RR, Gupta S, Kuo F, Makarov V, Sandhu A, Mano R, Silagy AW, Blum KA, Nassau DE, Benfante NE, Ortiz MV, Carlo MI, Chan TA, Motzer RJ, Voss MH, Coleman J, Russo P, Reuter V, Hakimi AA, Reznik E. Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy number variations as drivers of disease progression. Clin Cancer Res. 2020 Mar 27 [Epub ahead of print]
     View PubMed
111. Gupta S, Erickson LA. Fumarate Hydratase-Deficient Renal Cell Carcinoma. Mayo Clin Proc. 2020 Mar; 95 (3):619-621
     View PubMed
112. Gupta S, Vanderbilt C, Abida W, Fine SW, Tickoo SK, Al-Ahmadie HA, Chen YB, Sirintrapun SJ, Chadalavada K, Nanjangud GJ, Bialik A, Morris MJ, Scher HI, Ladanyi M, Reuter VE, Gopalan A. Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer. Prostate Cancer Prostatic Dis. 2020 Feb 24 [Epub ahead of print]
     View PubMed
113. Gupta S, Fine SW, Chang J, Tickoo SK, Chen YB, Al-Ahmadie HA, Sirintrapun SJ, Abida W, Ladanyi M, Reuter VE, Gopalan A. Morphologic and Immunohistochemical Assessment of CDH1 Loss of Function Alterations in Prostatic Adenocarcinoma. Am J Surg Pathol. 2019 Dec 24 [Epub ahead of print]
     View PubMed
114. Gupta S, Ito T, Alex D, Vanderbilt CM, Chang JC, Islamdoust N, Zhang Y, Nafa K, Healey J, Ladanyi M, Hameed MR. RUNX2 (6p21.1) amplification in osteosarcoma. Hum Pathol. 2019 Dec; 94:23-28 Epub 2019 Oct 25
     View PubMed
115. Chang JC, Alex D, Bott M, Tan KS, Seshan V, Golden A, Sauter JL, Buonocore DJ, Vanderbilt CM, Gupta S, Desmeules P, Bodd FM, Riely GJ, Rusch VW, Jones DR, Arcila ME, Travis WD, Ladanyi M, Rekhtman N. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach. Clin Cancer Res. 2019 Dec 1; 25 (23):7113-7125 Epub 2019 Aug 30
     View PubMed
116. Gupta S, Argani P, Jungbluth AA, Chen YB, Tickoo SK, Fine SW, Gopalan A, Al-Ahmadie HA, Sirintrapun SJ, Sanchez A, Hakimi AA, Mcfarlane T, Salazar PA, Williamson SR, Skala SL, Mehra R, Hes O, Antonescu CR, Ladanyi M, Arcila ME, Reuter VE. TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations. Am J Surg Pathol. 2019 Nov; 43 (11):1445-1461
     View PubMed
117. Gupta S, Cheville JC, Jungbluth AA, Zhang Y, Zhang L, Chen YB, Tickoo SK, Fine SW, Gopalan A, Al-Ahmadie HA, Sirintrapun SJ, Blum KA, Lohse CM, Hakimi AA, Thompson RH, Leibovich BC, Berger MF, Arcila ME, Ross DS, Ladanyi M, Antonescu CR, Reuter VE. JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management. Mod Pathol. 2019 Sep; 32 (9):1344-1358 Epub 2019 Apr 17
     View PubMed
118. Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, Leibovich BC, Thompson RH, Herrera-Hernandez L, Cheville JC, Jimenez RE. Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC. Hum Pathol. 2019 Sep; 91:114-122 Epub 2019 July 09
     View PubMed
119. Walasek A, Gupta S, Fine S, Russo P. Juxtaglomerular Cell Tumor: A Rare, Curable Cause of Hypertension in a Young Patient. Urology. 2019 Jun 21 Epub 2019 June 21
     View PubMed
120. Hau AM, Gupta S, Leivo MZ, Nakashima K, Macias J, Zhou W, Hodge A, Wulfkuhle J, Conkright B, Bhuvaneshwar K, Rao S, Madhavan S, Petricoin EF 3rd, Hansel DE. Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by Mammalian Target of Rapamycin Complex 2 in Bladder Cancer Cells. Am J Pathol. 2019 Jun 11 Epub 2019 June 11
     View PubMed
121. Gupta S, Sosa CP, Kosari F, Folpe A, Bhinge KN, Yang L, Agahi A, Johnson SH, Frank I, Boorjian SA, Hansel DE, Al-Ahmadie HA, Reuter VE, Vasmatzis G, Jimenez RE, Herrera-Hernandez L, Cheville JC. A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma. Hum Pathol. 2019 Jun; 88:48-59 Epub 2019 Apr 01
     View PubMed
122. Gupta S, Vanderbilt CM, Cotzia P, Arias Stella JA 3rd, Chang JC, Chen Y, Tang LH, DeLair DF, Yao J, Ladanyi M, Ross DS. JAK2, PD-L1, and PD-L2 (9p24.1) amplification in metastatic mucosal and cutaneous melanomas with durable response to immunotherapy. Hum Pathol. 2019 Jun; 88:87-91 Epub 2018 Sept 18
     View PubMed
123. Gupta S, Vanderbilt CM, Cotzia P, Arias-Stella JA 3rd, Chang JC, Zehir A, Benayed R, Nafa K, Razavi P, Hyman DM, Baselga J, Berger MF, Ladanyi M, Arcila ME, Ross DS. Next-Generation Sequencing-Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer: Potential Implications for Clinical Management. J Mol Diagn. 2019 Mar; 21 (2):307-317 Epub 2018 Dec 18
     View PubMed
124. Gupta S, Sahu D, Bomalaski JS, Frank I, Boorjian SA, Thapa P, Cheville JC, Hansel DE. Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20. Endocr Pathol. 2018 Sep; 29 (3):236-241
     View PubMed
125. Gupta S, Zhang J, Milosevic D, Mills JR, Grebe SK, Smith SC, Erickson LA. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127). Endocr Pathol. 2017 Sep; 28 (3):253-268
     View PubMed
126. Gupta S, Zhang J, Erickson LA. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase. Endocr Pathol. 2017 Sep; 28 (3):269-275
     View PubMed
127. Gupta S, Johnson SH, Vasmatzis G, Porath B, Rustin JG, Rao P, Costello BA, Leibovich BC, Thompson RH, Cheville JC, Sukov WR. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management. Mod Pathol. 2017 Jul; 30 (7):998-1012 Epub 2017 Mar 24
     View PubMed
128. Muppa P, Gupta S, Frank I, Boorjian SA, Karnes RJ, Thompson RH, Thapa P, Tarrell RF, Herrera Hernandez LP, Jimenez RE, Cheville JC. Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy. Pathology. 2017 Apr; 49(3):259-266. Epub 2017 Mar 01.
     View PubMed
129. Gupta S, Erickson LA. Testicular Seminoma. Mayo Clin Proc. 2017 Feb; 92 (2):e21-e22
     View PubMed
130. Sahu D, Gupta S, Hau AM, Nakashima K, Leivo MZ, Searles SC, Elson P, Bomalaski JS, Casteel DE, Boss GR, Hansel DE. Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2alpha Activity and Is Targetable by Pegylated Arginine Deiminase. Am J Pathol. 2017 Jan; 187 (1):200-213 Epub 2016 Dec 09
     View PubMed
131. Gupta S, Erickson LA. Paratesticular Adenomatoid Tumor. Mayo Clin Proc. 2016 Dec; 91 (12):e167-e168
     View PubMed
132. Gupta S, Jimenez RE, Folpe AL, Cheville JC. Renal Leiomyoma and Leiomyosarcoma: A Study of 57 Cases. Am J Surg Pathol. 2016 Nov; 40 (11):1557-1563
     View PubMed
133. Gupta S, Zhang J, Rivera M, Erickson LA. Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome. Endocr Pathol. 2016 Sep; 27 (3):243-52
     View PubMed
134. Sanfrancesco J, McKenney JK, Leivo MZ, Gupta S, Elson P, Hansel DE. Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition. Arch Pathol Lab Med. 2016 Jun; 140 (6):543-51 Epub 2016 Mar 31
     View PubMed
135. Gupta S, Hau AM, Al-Ahmadie HA, Harwalkar J, Shoskes AC, Elson P, Beach JR, Hussey GS, Schiemann WP, Egelhoff TT, Howe PH, Hansel DE. Transforming Growth Factor-beta Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion. Am J Pathol. 2016 May; 186 (5):1351-60 Epub 2016 Mar 14
     View PubMed
136. Gupta S, Naini BV, Munoz R, Graham RP, Kipp BR, Torbenson MS, Mounajjed T. Hepatocellular Neoplasms Arising in Association With Androgen Use. Am J Surg Pathol. 2016 Apr; 40: (4)454-61.
     View PubMed
137. Gupta S, Herrera Hernandez LP, Erickson LA. Diagnosing a Kidney Tumor. Mayo Clin Proc. 2016 Mar; 91: (3)e41-2.
     View PubMed
138. Gupta S, Erickson LA. Young Female Patient With a Hepatic Adenoma: Determining Risk for Malignant Transformation. Mayo Clin Proc. 2016 Feb; 91: (2)e29-30.
     View PubMed
139. Gupta S, Erickson LA. Pancreatic Tumor in a Patient With Parathyroid and Pituitary Disease. Mayo Clin Proc. 2016 Jan; 91 (1):e17-8
     View PubMed
140. Gupta S, Thompson RH, Boorjian SA, Thapa P, Hernandez LP, Jimenez RE, Costello BA, Frank I, Cheville JC. High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma. Pathology. 2015 Oct; 47 (6):533-42
     View PubMed
141. Poterucha JT, Johnson JN, Qureshi MY, O'Leary PW, Kamath PS, Lennon RJ, Bonnichsen CR, Young PM, Venkatesh SK, Ehman RL, Gupta S, Smyrk TC, Dearani JA, Warnes CA, Cetta F. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation. Mayo Clin Proc. 2015 Jul; 90 (7):882-94 Epub 2015 June 06
     View PubMed
142. Lohse CM, Gupta S, Cheville JC. Outcome prediction for patients with renal cell carcinoma. Semin Diagn Pathol. 2015 Mar; 32 (2):172-83 Epub 2015 Feb 07
     View PubMed
143. Khare R, Gupta S, Arif S, Jentoft ME, Deziel PJ, Roden AC, Wilhelm MP, Razonable RR, Wengenack NL. Misidentification of Neosartorya pseudofischeri as Aspergillus fumigatus in a lung transplant patient. J Clin Microbiol. 2014 Jul; 52 (7):2722-5 Epub 2014 May 14
     View PubMed
144. Guin S, Pollard C, Ru Y, Ritterson Lew C, Duex JE, Dancik G, Owens C, Spencer A, Knight S, Holemon H, Gupta S, Hansel D, Hellerstein M, Lorkiewicz P, Lane AN, Fan TW, Theodorescu D. Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease. J Natl Cancer Inst. 2014 Apr 3; 106 (5) Epub 2014 Apr 03
     View PubMed
145. Gupta S, Hau AM, Beach JR, Harwalker J, Mantuano E, Gonias SL, Egelhoff TT, Hansel DE. Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion. PLoS One. 2013; 8 (11):e81081 Epub 2013 Nov 27
     View PubMed
146. Xu X, Gupta S, Hu W, McGrath BC, Cavener DR. Hyperthermia induces the ER stress pathway. PLoS One. 2011; 6 (8):e23740 Epub 2011 Aug 18
     View PubMed
147. Cavener DR, Gupta S, McGrath BC. PERK in beta cell biology and insulin biogenesis. Trends Endocrinol Metab. 2010 Dec; 21 (12):714-21 Epub 2010 Sept 17
     View PubMed
148. Gupta S, McGrath B, Cavener DR. PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway. Diabetes. 2010 Aug; 59 (8):1937-47 Epub 2010 June 08
     View PubMed
149. Gupta S, McGrath B, Cavener DR. PERK regulates the proliferation and development of insulin-secreting beta-cell tumors in the endocrine pancreas of mice. PLoS One. 2009 Nov 24; 4 (11):e8008
     View PubMed
150. Feng D, Wei J, Gupta S, McGrath BC, Cavener DR. Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation. BMC Cell Biol. 2009 Sep 4; 10:61 Epub 2009 Sept 04
     View PubMed